Stay updated on CTX110 in B-Cell Malignancies Clinical Trial
Sign up to get notified when there's something new on the CTX110 in B-Cell Malignancies Clinical Trial page.

Latest updates to the CTX110 in B-Cell Malignancies Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe page shows a revision update from v3.6.4 to v3.6.5, indicating a deployed update to the site's underlying software. The change is a version bump rather than a content modification.SummaryDifference0.0%

- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedRevision: v3.6.4 is now displayed on the page, replacing v3.6.3. This indicates a software version update to the page without changes to study data or eligibility details.SummaryDifference0.0%

- Check50 days agoChange DetectedRevision label updated from v3.6.2 to v3.6.3. This indicates a small update to the page version rather than a change to the study content.SummaryDifference0.0%

- Check57 days agoChange DetectedThe page now shows a new revision tag: v3.6.2, replacing the older v3.6.0. This indicates a small backend or template update to how the page is rendered, without changing the study data presented to users.SummaryDifference0.0%

- Check71 days agoChange DetectedEnrollment status was updated to 'No longer looking for participants,' signaling that recruitment for this study has ended. The page also adds new help/navigation sections such as 'How to Read a Study Record,' 'Common Questions,' and 'How to Join a Study,' and updates the Intervention/Treatment label and revision information to reflect newer documentation.SummaryDifference0.4%

- Check79 days agoChange DetectedThe page displays a new revision label v3.5.5, replacing the previous v3.5.4 as part of a minor documentation update. This indicates a page revision without changes to the core study details.SummaryDifference0.0%

Stay in the know with updates to CTX110 in B-Cell Malignancies Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CTX110 in B-Cell Malignancies Clinical Trial page.